These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29902367)

  • 1. A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment.
    Ayyagari R; Xie J; Cheng D; Wu EQ; Huang XY; Chen S
    J Clin Hypertens (Greenwich); 2018 Jun; 20(6):1058-1066. PubMed ID: 29902367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung KC; Oh YS; Cha DH; Hong SJ; Won KH; Yoo KD; Rha SW; Ahn YK; Ahn JC; Jang JY; Hong TJ; Cho SK; Park SH; Hyon MS; Nam CW; Chae IH; Yoo BS; Song JM; Jeong JO; Yoon YW; Kim BS; Yang TH; Cho DK; Kim SH; Choi YJ; Ahn JH; Jeon DW; Kim HS
    Clin Ther; 2018 Jan; 40(1):50-63.e3. PubMed ID: 29248384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study.
    Cho EJ; Lee HY; Sung KC; Park S; Sohn IS; Park CG; Choi DJ; Ha JW; Ahn YK; Shin J; Hong SJ; Kim SK; Chung WJ; Yoo BS; Hong TJ; Youn HJ; Cho MC; Chae SC; Kim YJ; Kim CJ
    Am J Hypertens; 2019 Sep; 32(10):992-1002. PubMed ID: 31099387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
    Sison J; Assaad-Khalil SH; Najem R; Kitchlew AR; Cho B; Ueng KC; Shete A; Knap D
    Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol Effects on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients.
    Santos AH; Casey MJ; Bucci CM; Rehman S; Segal MS
    J Clin Hypertens (Greenwich); 2016 Aug; 18(8):741-9. PubMed ID: 26692375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
    Huan Y; Townsend R
    Expert Opin Pharmacother; 2012 Nov; 13(16):2409-15. PubMed ID: 23067322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of side effects of methyldopa, amlodipine, and metoprolol in pregnant women with chronic hypertension.
    Ghafarzadeh M; Shakarami A; Yari F; Namdari P
    Hypertens Pregnancy; 2020 Aug; 39(3):314-318. PubMed ID: 32420783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of aliskiren 300  mg/hydrochlorothiazide 25  mg (± amlodipine 5  mg) in hypertensive patients not controlled by candesartan 32  mg plus HCT 25  mg.
    Schweizer J; Ulmer HJ; Benduhn H; Klebs S
    Curr Med Res Opin; 2011 Jan; 27(1):131-40. PubMed ID: 21117946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY; Ahn T; Bae JH; Lim DS; Lee SU; Kim YK; Hyon MS; Kim WH; Han KR; Park HK
    Clin Ther; 2014 Oct; 36(10):1402-11. PubMed ID: 25146365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.
    Signorovitch JE; Samuelson TM; Ramakrishnan K; Marynchenko M; Wu EQ; Blum SI; Ramasamy A; Chen S
    Curr Med Res Opin; 2012 Apr; 28(4):591-9. PubMed ID: 22352883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe.
    Desideri G; Cipelli R; Pegoraro V; Ripellino C; Miroddi M; Meto S; Gori M; Fabrizzi P
    Curr Med Res Opin; 2024 May; 40(5):733-743. PubMed ID: 38459774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension.
    Palatini P; Malacco E; Fogari R; Carretta R; Bonaduce D; Bertocchi F; Mann J; Condorelli M;
    J Hypertens; 2001 Sep; 19(9):1691-6. PubMed ID: 11564991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension.
    Papademetriou V; Prisant LM; Neutel JM; Weir MR
    Am J Cardiol; 1998 Jun; 81(11):1363-5. PubMed ID: 9631978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.